
350.03 Delayed Data As of Dec 08 | ![]() Today’s Change | 282.21 Today|||52-Week Range 387.42 | +21.21% Year-to-Date |
The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 394.00, with a high estimate of 456.00 and a low estimate of 325.00. The median estimate represents a +12.56% increase from the last price of 350.03.
The current consensus among 30 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.